280. Deputy Pádraig O'Sullivan asked the Minister for Health the proportion of innovative oncology medicines approved at European level that are currently available and reimbursed in Ireland; the reason this proportion remains at approximately 25% given that the 180-day reimbursement timeline has been a legislative requirement under the Health Act 2013 for over a decade; the accountability measures that will be put in place to ensure the phased timeline under the new framework agreement is met at each stage; and if she will make a statement on the matter. [40640/26]

Summary

280. Deputy Pádraig O'Sullivan asked the Minister for Health the proportion of innovative oncology medicines approved at European level that are currently available and reimbursed in Ireland; the reason this proportion remains at approximately 25% given that the 180-day reimbursement timeline has been a legislative requirement under the Health Act 2013 for over a decade; the accountability measures that will be put in place to ensure the phased timeline under the new framework agreement is met at each stage; and if she will make a statement on the matter. [40640/26]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 27 May 2026

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.